share_log

JP Morgan Maintains Overweight on TransMedics Gr, Raises Price Target to $70

Benzinga ·  Nov 7, 2023 15:07

JP Morgan analyst Thomas Allen maintains TransMedics Gr (NASDAQ:TMDX) with a Overweight and raises the price target from $67 to $70.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment